AngioDynamics Reports Fiscal 2019 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
AngioDynamics (ANGO) Reports In-Line Q4 EPS, Offers FY20 Guidance
July 10, 2019 7:01 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $96.3 million versus the consensus estimate of $92.33 million.
GUIDANCE:
AngioDynamics sees FY2020 EPS of $0.25-$0.30, versus the consensus of $0.25. AngioDynamics sees... More
